Nucleoside triphosphate transporter and uses thereof

US10696719B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10696719-B2
Application numberUS-201916546097-A
CountryUS
Kind codeB2
Filing dateAug 20, 2019
Priority dateJun 24, 2016
Publication dateJun 30, 2020
Grant dateJun 30, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein are proteins, methods, cells, engineered microorganisms, and kits for generating a modified nucleoside triphosphate transporter from Phaeodactylum tricornutum . Also disclosed herein proteins, methods, cells, engineered microorganisms, and kits for production of a nucleic acid molecule that comprises an unnatural nucleotide utilizing a modified nucleoside triphosphate transporter from Phaeodactylum tricornutum.

First claim

Opening claim text (preview).

What is claimed is: 1. A recombinant nucleoside triphosphate transporter having an amino acid sequence selected from SEQ ID NO: 4, SEQ ID NO: 6, and SEQ ID NO: 8. 2. The recombinant nucleoside triphosphate transporter of claim 1 , wherein the recombinant nucleoside triphosphate transporter is encoded by an extrachromosomal nucleic acid molecule. 3. The recombinant nucleoside triphosphate transporter of claim 2 , wherein the extrachromosomal nucleic acid molecule comprises a nucleic acid sequence provided in SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 5, or SEQ ID NO: 7. 4. A prokaryotic cell comprising the recombinant nucleoside triphosphate transporter of claim 1 . 5. The prokaryotic cell of claim 4 , wherein the prokaryotic cell is an engineered cell. 6. The prokaryotic cell of claim 4 , wherein the prokaryotic cell is E. coli. 7. The prokaryotic cell of claim 4 , further comprising an unnatural nucleoside triphosphate transported into the prokaryotic cell using the recombinant nucleoside triphosphate transporter, wherein the unnatural nucleoside triphosphate comprises a base selected from the group consisting of: 8. The prokaryotic cell of claim 7 , wherein the unnatural nucleoside comprises a deoxyribose moiety. 9. The prokaryotic cell of claim 7 , wherein the unnatural nucleoside comprises a ribose moiety. 10. The prokaryotic cell of claim 4 , further comprising an unnatural base pair (UBP) comprising a first unnatural nucleoside and a second unnatural nucleoside, wherein the first unnatural nucleoside comprises a base that is and the second unnatural nucleoside comprises a base selected from the group consisting of 11. The prokaryotic cell of claim 10 , wherein the second unnatural nucleoside comprises a base that is 12. The prokaryotic cell of claim 4 , wherein the prokaryotic cell is isolated and purified. 13. A nucleic acid molecule encoding the recombinant nucleoside triphosphate transporter of claim 1 . 14. The recombinant nucleoside triphosphate transporter of claim 1 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 4. 15. The recombinant nucleoside triphosphate transporter of claim 1 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 6. 16. The recombinant nucleoside triphosphate transporter of claim 1 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 8. 17. The prokaryotic cell of claim 4 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 4. 18. The prokaryotic cell of claim 4 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 6. 19. The prokaryotic cell of claim 4 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 8. 20. The prokaryotic cell of claim 6 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 4. 21. The prokaryotic cell of claim 6 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 6. 22. The prokaryotic cell of claim 6 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 8. 23. The prokaryotic cell of claim 10 , wherein the cell is E. coli. 24. The prokaryotic cell of claim 23 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 4. 25. The prokaryotic cell of claim 23 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 6. 26. The prokaryotic cell of claim 23 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 8. 27. The prokaryotic cell of claim 11 , wherein the cell is E. coli. 28. The prokaryotic cell of claim 27 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 4. 29. The prokaryotic cell of claim 27 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 6. 30. The prokaryotic cell of claim 27 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 8.

Assignees

Inventors

Classifications

  • Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites · CPC title

  • C07K14/405Primary

    from algae · CPC title

  • DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity} · CPC title

  • Stable introduction of foreign DNA into chromosome · CPC title

  • Ribonucleases {[RNase]; Deoxyribonucleases [DNase]} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10696719B2 cover?
Disclosed herein are proteins, methods, cells, engineered microorganisms, and kits for generating a modified nucleoside triphosphate transporter from Phaeodactylum tricornutum . Also disclosed herein proteins, methods, cells, engineered microorganisms, and kits for production of a nucleic acid molecule that comprises an unnatural nucleotide utilizing a modified nucleoside triphosphate transpor…
Who is the assignee on this patent?
Scripps Research Inst
What technology area does this patent fall under?
Primary CPC classification C07K14/405. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).